Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
DMAC - OPERATING EXPENSES
Operating Expenses DMAC - DiaMedica Therapeutics Inc.
21.3 M
LAST VALUE
24.84%
2 YEAR CAGR
28.60%
5 YEAR CAGR
11.09%
10 YEAR CAGR